Evidence map›Paper›PMID 38792607›Full record

ArticleLife (Basel, Switzerland)2024

Comorbidities and Complications in People Admitted for Leprosy in Spain, 1997-2021.

Blanca Figueres-Pesudo, Héctor Pinargote-Celorio, Isabel Belinchón-Romero, José-Manuel Ramos-Rincón

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Blanca Figueres-PesudoInternal Medicine Service, General University Hospital Dr. Balmis, Alicante Health and Biomedical Research Institute (ISABIAL), 03010 Alicante, Spain.ORCID 0009-0002-2158-890X
Héctor Pinargote-CelorioInfectious Disease Unit, Internal Medicine Service, General University Hospital Dr. Balmis, Alicante Health and Biomedical Research Institute (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-3300-5807
Isabel Belinchón-RomeroDermatology Service, General University Hospital Dr. Balmis, Alicante Health and Biomedical Research Institute (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-6007-7320
José-Manuel Ramos-RincónInternal Medicine Service, General University Hospital Dr. Balmis, Alicante Health and Biomedical Research Institute (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-6501-9867

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to describe the epidemiological and clinical characteristics and trends of these admissions in Spain. This retrospective study drew data from the Hospital Discharge Records Database of the Spanish National Health System. We used the diagnostic codes for leprosy from the International Classification of Diseases, ninth and tenth revisions, to retrieve leprosy admissions from 1997 to 2021. There were 1387 hospitalizations for leprosy The number of annual cases decreased gradually, from 341 cases in 1997-2001 to 232 in 2017-2021 (

Indexed as

comorbidityepidemiologyhospitalizationsleprosySpain

Identifiers

PMID38792607
PMCPMC11121882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.